The Center of Excellence in Regulatory Science and Innovation (M-CERSI) is hosting a workshop at the Food and Drug Administration (FDA) in White Oak, Md.
The purpose of this one-day workshop is to solicit input from stakeholders on:
- Increasing the enrollment of historically underrepresented population in pediatric clinical studies
- Encouraging pediatric clinical study participation that reflects the prevalence of the other disease or condition among demographic subgroups, where appropriate and other topics
This workshop will be held in-person at FDA (in Great Room) and in a virtual format.
Registration is free, but required for both in-person and virtual attendance.
The agenda is also available online.